Osman, Norbaina .
HRN: 22-49-91 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2024
CO-AMOXICLAV 625MG (TAB)
04/28/2024
05/04/2024
PO
625mg
BID
RMLE
Waiting Final Action